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ABSTRACT  After  treatment  with  dexamethasone,  rat  hepatoma-tissue  culture  cells  show  a 
markedly  enhanced  adhesion  to  the  substratum  and  increased  cell-to-cell  interaction.  In 
addition, there is a profound  change  in the production  of secretory  glycoproteins. Although 
the  relative  synthesis  and  secretion  of  a gelatin-binding,  fibronectinlike  glycoprotein  is  in- 
creased  threefold,  we  do  not  think  this  protein  is  responsible  for  the  improved  adhesion 
properties of the cells because the hepatoma cells do not bind normal  fibronectin and because 
the  HTC-produced  fibronectin  is  neither  bound  by  fibroblasts  nor  has  it  any  affinity  for 
ganglioside-containing  phospholipid  vesicles.  Therefore,  these  hepatoma  cells  represent  a 
unique system for studying the regulation of fibronectin synthesis by glucocorticoids. Further- 
more,  analyses of  primary  fetal  rat  hepatocytes  have  shown  that these  cells,  unlike  normal 
adult hepatocytes,  synthesize and secrete fibronectin, which is structurally related  to the HTC- 
cell  protein. The comparison  of this protein  with fibronectin  from  normal  cells  will  allow  a 
structural  characterization  of  the  functional  defect  in  the  fibronectin  synthesized  by trans- 
formed cells. 
The nature of the support matrix for primary cultures of adult 
hepatocytes  has  been  found  to  be  an  important  factor  in 
maintaining the differentiated state of the cells  (1, 2). Several 
components are considered to be essential for providing suita- 
ble support conditions such as collagen (2, 3), fibronectin, and 
laminin (4, 5). Although all these components are integral parts 
of most basal membranes, only the two former are detectable 
in significant amounts in the biomatrix of normal-adult liver 
(6).  Due to the surface specialization of hepatocytes (7), only 
certain portions of the plasma membranes have contact with 
the extracellular matrix.  Excluded are the sinusoidal and bile 
canicular membranes,  which appear to be  free of adhesion- 
promoting proteins. Hepatoma cells have often been used for 
the biochemical analysis of adhesion and cell-to-cell interac- 
tion. These, in contrast to primary hepatocytes, offer the ad- 
vantage of being a stable and easily manipulable tissue-culture 
system. The tumor cells, however, poorly approximate the cell- 
surface domains characteristic of liver cells (8). Rat-hepatoma 
tissue culture (HTC) ceils, as well as other transformed liver- 
cell lines (9), have proven to be very useful in characterizing 
several liver-specific membrane phenomena (10). These partic- 
ular cells, however, have an additional unique feature, which 
is a glucocorticoid-mediated increase in cell adhesion (11,  12). 
We provide evidence in this communication that this hormone- 
effected  change  in  adhesion  is  independent  of fibronectin, 
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despite the concomitant increase in synthesis and secretion of 
that protein by the HTC ceils. Preliminary characterization of 
the  hepatoma  fibronectin  reveals  the  lack  of some  of the 
binding activities considered specific for fibroblast and plasma 
fibronectin. 
MATERIALS AND  METHODS 
Cells 
A newly cloned cell line of rat hepatoma-tissue culture cells (SR-HTC cells) 
and WI-38 human fibroblasts were grown in monolayer culture in Dulbecco's 
modified Eagle's medium  (DME)  containing  10% fetal calf serum  under an 
atmosphere of 5% CO2-95% air. Hormonal treatment of HTC cells consisted of 
the  addition of  1/~M  dexamethasone to  the  culture  medium.  Primary fetal 
hepatocytes were obtained by collagenase digestion of livers from 19-d fetuses of 
Buffalo rats following the procedure of Guguen-Guillouzo et al. (13). The cells, 
showing 95% viability as measured by trypan-blue dye exclusion, were seeded on 
collagen-coated 3.5-cm plastic petri dishes (2 x  l0  s cells in 2 ml) in DME lacking 
arginine but containing 2 mM L-ornithine, 10% dialyzed fetal calf serum, and 0.1 
ttM dexamethasone. The selective medium was changed after 2 h and then daily. 
The cells were used after 96 h  in culture. Fetal rat fibroblasts were obtained by 
digestion of the eviscerated body trunks of the rat fetuses with 0.05% trypsin in 
PBS containing 0.02% EDTA. The washed ceils were plated (3  ×  105 cells/10 
cm  2) and those adhering to the substratum after 2 h, were maintained in DME 
containing 10% fetal calf serum. After 4 d, secondary cultures were prepared and 
used for immunofluorescence studies.  For fibronectin-binding studies and for 
collection of metabolically labeled fibronectin, the cells were cultured in medium 
containing serum that was first passed through a  gelatin-Sepharose column in 
order to remove endogenous fibronectin. 
29 Labeling and Isolation of Fibronectin 
To obtain radiolabeled medium proteins, confluent cell monolayers were 
washed three times with serum-free or fibronectin-free medium and incubated 
for 24-48 li in the same medium (1.3 ml/10 cm  2 monolayer) containing either 
L-[5,6-SH]leucine (1.8 Ci/mmol), L-[6-aH]fucose (20 Ci/mmol), or L-[~Sl-methi  - 
onine (20 Ci/mmol). The culture media were centrifuged for 5 rain at  1,000 g 
and then for 60 rain at 200,000 g. The supernatant fractions were used directly 
for separation on two-dimensional gels (14)  or for isolation of fibronectin. To 
label rat-plasma flbronectin, 1 ml of citrated rat plasma was iodinated using I 
mCi  ~2BI and  1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril as catalyst (15).  The 
radioactive plasma-proteins were separated from the unincorporated label by 
passage  through  a  column  of Sephadex  G-25  (Pharmacia  Fine  Chemicals, 
Piscataway, N J). Fibronectin was purified from tissue-culture media or plasma 
by affmity chromatography on immobilized gelatin (16) following the procedure 
described  by  Sekiguchi et  al.  (17).  The  amount  of protein was determined 
according to Lowry et al. (18) using albumin as a standard. 
Gel Electrophoresis 
The separation of medium proteins or ftbronectin was carried out by two- 
dimensional  gel eiectrophoresis (14) using in the second dimension a uniform 7.5 
or 10% polyacrylamide gel. To compare proteins separated by two-dimensional 
gels, the spots were localized by autoradiography, cat out of the dried gel, and 
subjected to partial proteolytic digestion within a  15% polyacrylamide gel using 
Staphylococcus  aureus V8 protease (0.1 ~tg protease per well, digestion for 30 rain 
at 37°C) (19). The radio-labeled pattern was visualized by fluorography (20). 
Immunological Methods 
The total mixture of  proteins that are secreted by dexamethasone-treated HTC 
cells into serum-free culture medium, was used for immunization of a rabbit. Six 
subcutaneous injections, at 2-wk intervals, were carried out: the first was in 
complete, and the subsequent ones in incomplete Freund's adjuvant, and each 
contained 1 mg of protein. During the following 3 me, the animal was bled at 2- 
wk intervals. The pooled sera were used in this study. To obtain fibronectin- 
specific antibodies for immune  fluorescence studies, the immunoglobulins were 
collected from the above serum pool by twice precipitating with 40% saturated 
(NH4)2SO4. The immunoglobulins were redissolved in 0.2 M sodium carbonate, 
pH 9.0 (30 mg/ml), and reacted with fluorescein isothiocyanate (modification: 
1.5 mol/mol immunoglobulins)  (2 I). The fluorescent antibodies were then passed 
through a l-ml column of Sepharose 4B-CL to which 2 nag of purified rat plasma 
fibronectin was covalently  coupled (16). The bound immunoglobulins  were eluted 
in 0.2 M glycine-HCl, 4 M guanidine HCI, pH 3.0, and then chromatographed 
on Sepliadex G-25 in PBS. For immunoftuorescence studies, HTC cells, and fetal 
rat flbroblasts were grown on glass cover slips placed in 3.5-cm dishes. The cells 
were washed three times with culture medium and then incubated for 30 min at 
4* in 1 ml medium containing 10 #g fluorescent antifibronectin immunoglobulin. 
The cells were inspected using a Leitz-fluorescence microscope. 
To quantify the absolute amount of secreted fibronectin, confluent monolayers 
(75 cm  2) of HTC cells were incubated for 24 h in 10 ml of flbronectin-free culture 
medium. The  ultracentrifuged media were dialyzed for 24 h  against 50 mM 
NH41-ICOa containing 0.1 mM phenylmethylsuffonyl fluoride (PMSF) and then 
freeze-dried. The residues were redlssolved in 1 ml of PBS containing 1% NP-40, 
0.1 mM pheaylmethylsalfonyl  fluoride. Aliquots of 15 #1 of concentrated media 
or purified fibronectin were analyzed by standard crossed immuaoelectrophoresis 
on 1% agarose gels (10 ×  10 cm) in 45 mM Tris, 100 mM glycine, 40 mM barbital 
buffer, pH 8.5, containing 1% NP-40 (22). The first dimension was run at 5 V/cm 
for 4 h and the second at 2 V/cm for 22 h into an agarose gel containing 5% (vol/ 
vol) of rabbit antiserum against HTC-cell secretory proteins. The pauerns were 
visualized by staining with Coomassie Brilliant Blue or by fluorography. The 
fibronectin peak was quantitatively analyzed by measurement of the area under 
the precipitin line and compared to known quantities of fibronectin. The values 
are expressed in micrograms of fibronectin secreted per day and per milligram  of 
total cell protein measured at the time of medium collection. 
Cell Attachment Assay 
The assays were carried out essentially as described by Sekigucki and Hake- 
moil (23). In brief: plastic tissue culture plates with six wells (3.5-cm  diameter; 
Costal Data Packaging, Cambridge, MA) were incubated at room temperature 
with 2 ml of PBS containing 1 mM CaCh, 1 mM MgClz, and 0. I mM PMSF and 
40 ~g of flbronectin from either rat plasma or HTC cells.  After 4  h,  the wells 
were washed extensively with PBS.  Some wells were then incubated for 1 h  at 
room temperature with 2  ml of buffer containing 100 ~g of affinity-purified 
rabbit anti-rat fibronectin (see above). WI-38 fibroblasts and HTC  ceils were 
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released from monolayers by treatment with trypsin-EDTA and washed once 
with fibronectin-free culture medium followed three times with PBS. Aliquots of 
2 ml ofcen suspension (6 ×  105 WI-38 fibroblasts and 1.5 x  l0  s HTC cells) were 
added to the test well and incubated for 1 h  at 37°C. The adherent cells were 
photographed using a Nikon inverted phase-contrast microscope. 
Binding of Fibronectin to Reconstituted 
Phospholipid Vesicles 
Phospholipids used for  reconstitution were purified from  rat-liver plasma 
membrane fractions or [32P]phosphate labeled HTC-cell membranes as described 
elsewhere (24).  Total gangliosides were purified from rat brain as outlined by 
Salto and Hakomori (25). The gangliosides  in the final preparation were separated 
by thin-layer chromatography and visualized by staining with resorcinol (26). 
Sealed and unilamellelar phospliolipid vesicles were reconstituted by deoxycho- 
late dialysis using lmg of phospliolipids, alone or combined with 80 t~g gangLio- 
sides/ml reconstitution mixture (24). The formed vesicles were diluted with 50 
mM Tris-HCl, 140 mM NaCI, and 1 mM CaCh, pH 7.6, (= TBS) and brought 
to  40%  (wt/vol)  with  solid sucrose  resulting in  a  concentration  of  500  t~g 
phospholipid vesicles/mL Aliquots of I ml of vesicle suspension were placed into 
12-ml nitrocellulose ultracentrifuge tubes for rotor SW41 (Beckman Instruments, 
Inc.,  Spinco Die., Pale Alto, CA). The vesicles were sequentially overlaid with 
0.5 ml of 35% sucrose in TBS containing 1.5-2 pg isotopically  labeled fibronectin, 
6 ml of 30% sucrose in TBS, and 4 ml of TBS. After centrifugation for  16 h at 
20@000 g at 20°C, the contents of the tubes were removed by an Isco fractionator 
and collected in 370 #1 fractions. Aliquots of 50 td from each fraction were used 
for radioactivity measurements by scintillation  counting. 
RESULTS 
HTC cells, which have been used in previous studies (27, 28), 
were found to have a rather weak interaction with the substra- 
tum  and  between  one  another  when  grown  in  monolayer 
culture. The cells remain isolated and loosely attached to the 
culture dish and would not form confluent monolayers. When 
we established new cloned cell lines from the wild-type SR- 
HTC cells  (27),  we observed several clones that exhibited  a 
preference  to  grow in  clusters.  One  of these  cell  lines  was 
selected and used in this study. The cells  responded to dexa- 
methasone with an increase in adhesiveness to the substratum, 
as has already been reported  for the original  SR-HTC cells 
(12), and also with tighter cell-cell interaction. This feature is 
most apparent  in the altered  morphology of the monolayer 
(Fig.  1). This enhanced adhesion and spreading of HTC cells 
after dexamethasone treatment is reminiscent of the morpho- 
logical alterations seen in primary hepatocytes when fibronec- 
tin is provided as culture substratum (5). Possible explanations 
for these dexamethasone-induced phenomena include: (a) an 
increased amount of fibronectin in the HTC cell culture, (b) an 
improved ability of the cells to utilize the fibronectin present 
in  the  culture  medium,  or  (c)  an  expression  of membrane 
properties that are independent of fibronectin. 
To differentiate between these possibilities,  we first analyzed 
the effect of the steroid hormone on the pattern  of proteins 
secreted  by the hepatoma cells  into the culture  medium. As 
shown in Fig. 2, within 24 h dexamethasone elicited a drastic 
change  in  the  qualitative  and  quantitative  composition  of 
fucose-labeled medium proteins. Some of  these alterations were 
identical to those detected in other cell lines of SR-HTC cells 
(27). Besides the increased synthesis and secretion of the two 
glycoproteins, gp50 and at-acid glycoprotein (= gp35-50) (28), 
a third glycoprotein species with apparent molecular weight of 
230,000 was also present in an elevated amount (marked with 
FN in Fig. 2). To demonstrate that this spot represents a protein 
with properties of fibronectin, we collected the culture media 
from HTC  cells  metabolicaUy-labeled  with  [aH]leucine  and 
chromatographed it on a gelatin-Sepharose colunm. A steroid- 
dependent increase in the radioactivity recovered in the gelatin- FIGURE  1  Effect of dexamethasone on the morphology of HTC cell  monolayers. HTC cells were grown for 48 h  in  monolayer 
culture. Fresh culture media were then added. To one culture 1 #M dexamethasone was added. After 24  and 48 h, the cells were 
photographed under a phase-contrast microscope, x  250. 
BAUMANN AND ELDREDGe  Effect of Dexamethasone on Fibronectin Synthesis  3"1 FIGURE  2  Glycoproteins  synthesized  and  secreted  by  HTC  cells.  Confluent  monolayers of  HTC  cells,  (A),  control  and  (B), 
pretreated for 24 h with dexamethasone, were metabolically labeled for 24 h with  in serum-free medium containing [3H]fucose 
(100 #Ci/ml). Aliquots of 50/~1 of the cell-free culture medium, containing 250,000 and 490,000 acid-insoluble cpm, respectively, 
were subjected  without further treatment to two-dimensional separation on  polyacrylamide gels. The fluorographs are shown 
after a 3-wk exposure. FN, fibronectin; gp, glycoprotein; ~, AGP, ~,-acid glycoprotein. MW,  mot wt;  BPB, bromphenol blue. 
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fibronectin  after  chromatography  on 
ge[atin-Sepharose.  HIC  cells,  treated 
with  dexamethasone,  were  labeled 
with [3H]leucine  (see Table I). The me- 
dia  were  chromatographed  on  1-ml 
columns of gelatin-Sepharose. The gel- 
atin-bound  material  was  eluted  and 
one-half was separated on a 7.5% poly- 
acrylamide gel. The distribution  of the 
radioactivity on the gel was determined 
in  2-ram  thick  slices.  The  inset  shows 
the  fluorographic  picture  of  the  same 
fibronectin  preparation separated on a 
5%  polyacrylamide  gel  either  under 
nonreducing  (1)  or reducing  (2)  con- 
ditions.  MW,  mol wt. 
bound  fraction  was  observed.  PAGE  of the  affinity-purified 
material under reducing conditions revealed that the majority 
of the radioactivity appeared  in a  single band migrating with 
Mr 230,000,  and under nonreducing  conditions in two bands, 
a minor one at Mr 230,000 and a major one at Mr 450,000 (Fig. 
3). The same molecular weights are found  for the fibronectin 
purified from rat plasma (data not shown). These values are in 
agreement with those molecular weights reported for the mon- 
omeric and  dimeric forms  of plasma  flbronectin  from other 
sources (17, 29). Quantitative determination of the radioisotope 
in the gelatin-bound material (Table I) reveals that dexameth- 
asone treatment elicits a two- to fourfold increase in the relative 
synthesis  and  secretion  of that  protein,  depending  upon  the 
type of precursor provided. 
The use of radioactive metabolites to determine the influence 
of the glucocorticoid on the fibronectin synthesis is, however, 
complicated by the effect of the hormone on the uptake of the 
precursors (see legend  to Table  I  and  references  10,  27).  Al- 
though  valid  estimates of the  hormone  effect  on  fibronectin 
production can be obtained by expressing the measurements as 
relative values,  we determined the  absolute  amount of fibro- 
nectin secreted by HTC cells using immunological means. To 
do  so, we immunized a  rabbit  with  the  secretory proteins  of 
dexamethasone-treated  HTC  cells.  The  antiserum  obtained 
was used to analyze the antigenic composition of conditioned 
HTC-cell  culture  medium by crossed immunoelectrophoresis 
(Fig.  4). The antigens in the three major precipitin lines were 
identified  by reelectrophoresis of the material recovered from 
crossed  immunoelectrophoresis  plates  on  two-dimensional 
polyacrylamide gels (data not shown). The migration of affinity 
purified rat-plasma fibronectin on crossed immunoelectropho- 
resis plates  is identical  to that  of HTC  ceils (Fig.  4 C).  Both 
fibronectins  share  all  antigenic  determinants  as judged  from 
tandem crossed-immunoelectrophoresis analysis and they yield 
the same peak area per p.g of applied protein (data not shown). 
Furthermore,  we  could  not  detect  any  cross  reaction  of the 
antiserum with bovine or human plasma fibronectin. 
gAUMANN AND  ELDREDGE 
TABLE  I 
Effect of Dexamethasone on the Synthesis and Secretion of 
Fibronectin in HTC Cells 
Analyzed  fraction 
Me- 
Cell  dium 
Experiment  proteins  proteins  Fibronectin 







52.4  2.3  0.17 
60.0  1.9  0.09 
35.2  2.7  0.71 
37.0  3.1  0.84 
3,790  700  17 
3,890  580  12 
3,510  1,210  59 
3,670  1,050  50 
Immu noelectrophoresis§ 
Control  7.7 +  1.9 
Dexamethasone  20.4  _  2.6 
* Confluent monolayers  (10 cm  2) were treated  with or without dexametha- 
sone for 24 h. The cells were then labeled  for 24 h in serum-free  medium 
containing either [aH]leucine  (100/~Ci/ml)  or [3H]fucose  (100 #Ci/ml). The 
fibronectin  present in the culture fluid was purified  by chromatography on 
gelatin-Sepharose  followed by electrophoresis  on 7.5% polyacrylamide  gel 
under reducing  conditions  (see Fig. 3). Values from two identically  treated 
monolayers are shown and represent specific radioactivities  (cpm/#g of total 
cell  proteins). 
Treatment  of HTC cells with dexamethasone  for 24 h causes a reduction  in 
the uptake  of leucine.  When  the uptake of [aH]leucine  within 30 rain was 
measured,  using the  conditions  described  above  and  in  Materials  and 
Methods,  control  cells  have  a value  of 810 cpm//~g  and  dexamethasone 
treated cells a value of 690 cpm/#g 
§ Confluent monolayers  (75 cm  2) were treated  with or without dexametha- 
sone  for 24  h,  The  cells  were then  incubated  for  an  additional  24  h  in 
fibronectin-free  medium. The  media  were concentrated  lO-fold  and  ana- 
lyzed  by  crossed  immunoelectrophoresis  as  described  in  Materials  and 
Methods.  The amount of fibronectin  was determined and expressed in/~g 
fibronectin/24 h/mg of total  cell-protein.  The values  represent  the mean 
and standard deviation  of four independently conducted experiments. 
Effect of Dexamethasone on Fibronectin Synthesis  33 FIGURE  4  Crossed  immunoelectrophoretic analysis of the secreted 
glycoproteins of  HTC  cells.  HTC cells,  (A),  control, and  (B),  pre- 
treated for 24  h  with  dexamethasone, were metabolically labeled 
for 24  h  with  fibronectin-free  medium containing  [3H]fucose  (10 
gCi/ml).  The media were concentrated 10-fold and aliquots of  15 
gl  separated  by  crossed  immunoelectrophoresis. The  radioactive 
patterns were visualized by fluorography (1-wk exposure). In C, 0.5 
gg of affinity purified rat-plasma fibronectin was analyzed. The gel 
plate was stained with Coomassie Blue. gp 50, glycoprotein with Mr 
50,000. 
The immunoelectrophoretic analysis and quantification  of 
fibronectin in several HTC-cell medium preparations indicate 
a threefold increase in the fibronectin concentration after treat- 
ment of HTC cells with dexamethasone (Table I). This t'mding 
agrees closely with the results of the metabolic labeling studies. 
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Although HTC cells  release more fibronectin into the sur- 
rounding milieu after exposure to dexamethasone, monolayers 
of control or hormone-treated cells appear to bind little or no 
fibronectin,  as judged  by  the  very  low  level  of detectable 
fluorescence when the cells were probed in situ with fluorescein- 
labeled antifibronectin immunoglobulins (Fig. 5 A and B). Nor 
does the addition of rat-plasma fibronectin to dexamethasone- 
treated HTC cells lead to an enhanced fluorescence (Fig. 5 C). 
The absence of externally bound fibronectin was confirmed by 
cell-surface  labeling  procedures.  The  treatment  of HTC-cell 
monolayers with either lactoperoxidase-Na I25I or neuramini- 
dase-galactose oxidase-NaB[3H]4  did not result in labeling of a 
protein comigrating with fibronectin on two-dimensional poly- 
acrylamide gels (data not shown, see  similar results in refer- 
ences 30, 31). 
To  determine  whether  SR-HTC cells  indeed  do  not  bind 
fibronectin and/or whether the fibronectin produced by HTC 
cells lacks actual cell-binding activity, we purified fibroneetin 
known to have all binding activities (see reference 17) and that 
could also be metabolically labeled in a manner comparable to 
that of HTC cells. We chose WI-38 human-diploid fibroblasts 
as a  source of medium fibronectin, because among all fibro- 
blast-cell lines these ceils were found to synthesize the greatest 
amount  of cell-bound  and  secreted  fibronectin  (32).  Using 
[3H]-fucose  for metabolic  labeling  and  gelatin  aft'ralLy chro- 
matography,  we  obtained  fibroblast  fibronectin,  which  ap- 
peared on two-dimensional gel as a  single  spot and did not 
differ  significantly  in  its  electrophoretic  mobility  from  the 
hepatoma  product (data  not  shown).  These  two  fibronectin 
preparations were subsequently used in bioassays (33,  34) to 
test the binding activites of both the cells and the fibronectins 
(Table  II). To exclude  the  possibility that there  are species- 
specific binding  properties,  we  also  studied  125I-labeled rat- 
plasma fibronectin (Experiment II in Table II). It appears that 
HTC cells, with or without dexamethasone treatment,  do not 
bind  appreciable  amounts of either their  own fibronectin or 
that of fibroblasts. In addition, the HTC-cell-derived fibronec- 
tin  was bound to WI-38 cells much less  efficiently than the 
fibroblast or rat-plasma fibronectin. 
Despite the lack of binding of soluble fibronectin of HTC 
ceils  to cells,  the  possibility still  exists  that  this  protein  can 
promote cell attachment and spreading. Therefore, we coated 
culture  substrata  with  fibronectin  from either  rat  plasma or 
HTC  cells.  Using  WI-38  fibroblasts  and  dexamethasone- 
treated HTC cells  as test cells for the activity of the prepared 
surfaces,  we  observed  that  the  adhesion  of fibroblasts  was 
promoted  only by plasma-derived  fibronectin  and  that  this 
activity could be abolished by pretreatment of the coated plate 
with  antibodies  against fibronectin (Fig. 6).  The attachment 
and spreading of HTC cells,  however, were not significantly 
influenced by the nature of the culture substratum.  A similar 
test employing hormone-untreated HTC-cells yielded the same 
results (data not shown). 
To corroborate the partial  activity of HTC-cell fibronectin 
using another system, we took advantage of the observation of 
Kleinman and co-workers (35, 36) that fibronectin has a spe- 
cific affinity to more highly sialylated gangliosides.  This hy- 
pothesis is attractive with respect to the hepatoma-cell system, 
for HTC cells do not contain any ganglioside species with more 
than one sialic acid residue per molecule (26). The lack of these 
membrane constituents might explain the absence of fibronec- 
tin binding, despite the observation that highly sialylated gan- 
gliosides were minimally present in nontransformed fibroblasts, FIGURE  5  Cell-surface  localization of fibronectin  by fluorescent  immunoglobulins.  HTC cells, control  (A)  and treated for 48 h 
with dexamethasone (B and C) and fetal-rat fibroblasts (D), were cultured on glass cover slips. To the medium (2 ml) of the cells 
in  C, 100/~g of affinity  purified rat-plasma fibronectin was added after 24-h  hormone treatment. The presence of surface-bound 
fibronectin was assessed by fluorescent antibodies against rat fibronectin.  Left,  light-microscopic  picture, x  400; and  right,  the 
fluorescent image of the same cells. 
35 TABLE  II 
Association of Exogenously Added Fibronectin to HTC Ceils 
and WI-38 Fibroblasts 
Cells tested 
Radioactive  fibronectin 
bound 
Wl-38-  Rat- 
HTC-cell  cell  fi-  plasma 
fibro-  bronec-  fibro- 
nectin  tin  nectin 
#g/mg of total cell protein 
Experiment I 
HTC cells 
Control  0.7  0.5 
0.9  0.5 
Dexam~  Lsone-treated  0.5  0.5 
0.6  0.9 
WI-38 Fibroblasts  2.8  9.1 
3.3  13.5 
Experiment  II 
HIC ceils 
Control  0.1  0,1 
0.1  0,1 
Dexamethasone-treated  0.1  0.1 
0.2  0,1 
Wl-38 
Control  0.7  8.7 
0.7  8.4 
With excess rat-plasma fibro-  0.5  0.5 
nectin  0.7  0.6 
To  obtain  metabolically  labeled  fibronectin  for binding  studies  four  flasks 
(150 cm2), each of confluent  HTC cells  treated with dexamethasone, and WI 
38 fibroblasts were labeled with [3H]fucose (10#Ci/ml)  for48 h in fibronectin- 
free  medium.  The  synthesized  and  secreted  fibronectins  were  purified  by 
gelatin  affinity chromatography.  To test the binding  specificity  (Experiment 
II), we prepared  1251-labeled fibronectin  from  rat plasma.  The final prepara- 
tions  had the following  specific  radioactivities:  HTC-cell  tibronectin,  20700 
cpm/#g  (Experiment  I); and 8,400 cpm/#g  (Experiment II); Wl-38 fibronectin: 
4,300 cpm/#g;  and  rat plasma fibronectin:  87,000 cpm/#g.  HTC cells,  with or 
without  prior  dexamethasone  treatment,  as well  as  WI-38  fibroblasts  were 
released  from  monolayers  by  trypsin.  The  cells  were  washed  once  with 
fibronectin-free  medium  and  resuspended  in  the  same  medium  yielding 
densities of 1 x  10  a HTC cells/ml  and 5 X  105 Wl-38  fibroblasts/ml.  2 ml of 
the cell suspensions were placed into 2S-cm 2 plastic dishes.  Before use, these 
culture dishes were incubated  with 5 ml fibronectin-free  medium  for 2 h at 
room  temperature.  To  each  culture  (in  duplicates),  15 #g  of  radiolabeled 
fibronectin  was added.  We  tested  the  binding  specificity  of  fibronectin  to 
fibroblasts  by adding  in  Experiment  II, to some of the Wl-38  cultures,  1251- 
labeled  rat-plasma  fibronectin  together with an excess  (250,ug)  of unlabeled 
fibronectin. After 24 h in culture, the cells attached to the dishes were washed 
three times  with  PBS. The acid-precipitable  radioactivities  bound  to the cell 
monolayers  as  well  as  the  total  amount  of cell  protein  were  determined. 
Based on the known specific activities of the fibronectin  preparations, the p,g 
amounts of fibronectin  bound per mg of total cell protein were calculated. To 
estimate the degradation  of radioactive fibronectin,  the cells from the culture 
media after a 24-h incubation were passed through gelatin-Sepharose columns 
and the bound material analyzed on polyacrylamide gels.  In all cases, 92-96% 
of the radioactivities  present in the media after 24 h were still associated  with 
intact fibronectin. 
and with the subsequent conclusion by Rauvala et al. (37) that 
these plasma-membrane constituents do not act as true cell- 
surface receptors for fibronectin.  Nevertheless,  we used  this 
peculiar binding property to analyze the activity of hepatoma 
and fibroblast fibronectin. The assay system consisted of phos- 
phovesicles carrying higher sialylated gangliosides that were 
centrifuged through a layer of [3H]fucose-labeled  fibronectin. 
If binding of fibronectin to the vesicles  takes place, it can be 
detected by comigration of tritium with the phospholipid ves- 
icles (Fig. 7). To mark precisely the position of the isopycnically 
concentrated vesicles in the centrifuge tube, we utilized radio- 
labeled vesicles prepared by addition of trace amounts of 32p_ 
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labeled phospholipids to the reconstitution mixture. Although 
this assay system allows only a qualitative assessment of bind- 
ing activity, it  clearly shows that the fibronectin  from HTC 
cells, unlike that from fibroblasts, lacks any detectable  inter- 
action with the artificial membrane. This result, combined with 
the  previous  data  in  Table  II, indicates  that  although  it  is 
structurally similar to fibroblast fibronectin, hepatoma fibro- 
nectin shares only partial activity with that for fibroblasts. 
To study further the structural properties of HTC-cell fibro- 
nectin,  we needed  for appropriate  comparison  a  fibronectin 
molecule  that  is  synthesized  by  nontransformed  cells  (34). 
Because the HTC cells are of hepatic origin, the logical source 
of such fibronectin would be parenchymal cells  of the liver. 
Previous labeling experiments have shown, however, that pri- 
mary  cultures  of fully  differentiated  adult  rat  hepatocytes, 
whether or not they are treated with dexamethasone,  do not 
synthesize or secrete detectable  amounts of fibronectin (28). 
Therefore, we analyzed primary cultures of fetal rat hepato- 
cytes. As shown in Fig. 8A, fibronectin represents a significant 
portion of the proteins synthesized and secreted by these cells. 
We have confirmed that this  protein  binds to gelatin  and  is 
recognized by the anti-rat fibronectin immunoglobulins (data 
not  shown).  For  structural  comparison,  [3~S]methionine-la- 
beled,  monomeric fibronectin from fetal rat hepatocytes and 
from HTC cells  were recovered from two-dimensional poly- 
acrylamide gels and analyzed by partial proteolytic mapping 
(Fig. 8 B). To demonstrate the validity of proteolytic compari- 
son for proteins that are shared between fetal hepatocytes and 
the  HTC  cells,  we  included  a  similar  digestion  of gp50,  a 
glycoprotein that is, like fibronectin, regulated by dexametha- 
sone in hepatoma cells  and is exclusively expressed  by fetal 
hepatocytes (for data on adult hepatocytes, see reference 28). 
The  peptide  patterns  of the  proteins  from  the  two  former 
sources  show almost  perfect  homology indicating  structural 
similarity of the polypeptide moieties.  Close inspection of the 
fragmentation  pattern  of the  fibronectin  proteins,  however, 
reveals one band differing in mobility (indicated by arrow in 
Fig. 8 B). Whether this structural difference is connected with 
the  reduced  biological  activity of the  hepatoma  fibronectin 
remains  to  be  analyzed.  Furthermore,  we  do  not  yet  have 
sufficient data to determine whether or not fibronectin synthe- 
sis and secretion in fetal hepatocytes are regulated  by gluco- 
corticoids. 
DISCUSSION 
We have attempted to determine whether fibronectin plays any 
role in the adhesion and cell-cell interaction of rat hepatoma 
cells.  Two distantly related  phenomena have stimulated  this 
line of  investigation: first, nontransformed adult rat hepatocytes 
require  for  adhesion  and  spreading  either  collagen  (3)  or 
fibronectin (5),  both components of the liver matrix (2), and 
secondly, hepatoma cells exhibit a marked increase in adhesion 
to  the  substratum  upon  dexamethasone  treatment  (12).  An 
additional intriguing observation is that dexamethasone elicits 
in HTC cells an increased synthesis and secretion of a glyco- 
protein with gelatin-binding activity, similar in size and charge 
to  the  soluble  fibronectin  of fibroblasts  and  containing  the 
same antigenic determinants  as  rat plasma  fibronectin.  Two 
results  strongly suggest  that the steroid-induced adhesion and 
spreading properties of HTC cells are not mediated by fibro- 
nectin. First, in HTC cells, no significant amount of fibronectin 
protein is accessible  to immunoglobulin probing (Fig. 4) or to 
radioactive modification  by cell-surface labeling  techniques. FIGURE  6  Attachment of cells to fibronectin-coated culture surfaces.  HTC cells,  treated for 48 h with dexamethasone, and Wl-38 
fibroblasts were incubated in nontreated plates (A) and plates coated with  HTC cell fibronectin  (B), with rat-p]asma fibronectin 
(C), and with rat-plasma fibronectin exposed to antifibronectin immunoglobulin (D). x  240. 
37 38  THE  JOURNAL OF  CELL BIOLOGY • VOLUME 95, 1982 FiGure  8  Analysis of the proteins secreted by primary fetal hepatocytes. A: After 4 d  in culture, primary fetal tat hepatocytes in 
a 3.5-cm dish were labeled for 24 h with  [35S]methionine in serum-free medium. An  aliquot of the culture medium, containing 
200,000 acid-insoluble cpm, was separated by two-dimensional polyacrylamide gels. The pattern was visualized by fluorography 
(2-wk exposure). Arrows indicate the position of: albumin (1), ~l-fetoprotein (2), transferrin (3), glycoprotein with Mr 50,000 (gpS0) 
and fibronectin (FN).  B: Concentrated media containing [3SS]methionine-labeled proteins of fetal rat hepatocytes and dexameth- 
asone-treated HTC  cells  (each  preparation containing  1.2 x  106 cpm) were separated as in  A  and the spots corresponding to 
fibronectin and to gp50 were analyzed by partial proteolytical digestion with S. aureus  protease on a 15% polyacrylamide gel (19). 
The lanes represent  1,  rat-hepatocyte gp50 without  protease; 2,  rat-hepatocyte gp50;  3,  HTC-cell  gp50 with 3  N-g[ycans  (see 
reference 28);  4, rat-hepatocyte fibronectin without protease; 5,  rat-hepatocyte fibronectin; 6,  HTC-cell fibronectin. To achieve 
comparable intensities, the various lanes were exposed for periods ranging from 2 to 14 d. Arrow indicates the difference in the 
peptide pattern of HTC-cell fibronectin. 
However,  using  the  same  labeling techniques  for  fibroblast 
monolayers, fibronectin appears as the  most prominently la- 
beled component  (38,  39).  Second, neither exogenously sup- 
plied fibroblast fibronectin nor its own fibronectin were bound 
by HTC cells (Fig. 5 and Table II). The absence of fibronectin 
on the cell surface of HTC cells is not unique to this cell type, 
as two other hepatoma-cell lines, mouse Hepa II cells and rat 
H-35 cells, do not display surface-bound fibronectin (H. Bau- 
mann,  unpublished observations). Furthermore, unlike HTC 
cells, these two hepatoma-cell lines do not synthesize or secrete 
detectable  amounts  of  fibronectinlike  proteins  under  any 
known  hormonal  culture  conditions.  From  these  data,  the 
specific identity of the cell-surface component(s) responsible 
for adhesion either in HTC cells or other hepatoma cells is not 
apparent. Moreover, we have at the present time no evidence 
whether  these  hepatoma  cell lines  synthesize and  secrete  a 
protein that promotes cell attachment, but is structurally dif- 
ferent from fibronectin and does not bind to gelatin (40). 
Because a  role for fibronectin in the adhesion of nontrans- 
formed  hepatocytes  has  not  been  clearly established  (3-5), 
speculation about a possible loss of fibronectin recognition by 
hepatoma cells due to transformation is not warranted. How- 
ever, that transformation can indeed lead to reduced fibronec- 
tin-binding has been demonstrated for hamster fibroblasts (34). 
Although fibronectin synthesized by HTC cells binds appro- 
priately to gelatin, it appears not to be a completely functional 
fibronectin, because it binds only partially to fibroblasts and 
not  at  all  to  ganglioside-containing  phospholipid  vesicles. 
Whether  the  binding activities for  other  molecules such  as 
glycosaminoglycans (41), fibrin (42), DNA (43),  S. aureus (44), 
or actin (45) are still preserved, remains to be determined. The 
occurrence of functionally defective fibronectin is not unique 
to HTC cells, as there are reports of the production of similarly 
inactive fibronectin by senescent human fibroblasts (46) and of 
the presence of defective plasma fibronectin in a  patient with 
Ehlers-Danlos  syndrome  (47).  This  report  of  a  fibronectin 
protein with partial activity provides the opportunity to study 
the  specific structural or chemical requirements  for binding 
activity. 
During the process of transformation and culture selection, 
HTC cells have retained few properties that are considered to 
be liver-specific; most noted are the glucocorticoid-regulated 
FiGURe 7  Binding of fibronectin to ganglioside-containing phospholipid vesicles.  Phospholipid vesicles,  with or without ganglio- 
sides, were prepared as described in  Materials and Methods. The vesicles that were used  in the separations shown  in the top 
panels, contained in addition 38,000 cpm of [32p]  phospholipids. Aliquots of the vesicle preparations were placed into ultracentrifuge 
tubes overlaid with 0.5 ml of sucrose solution containing either 1.6/~g of HTC-cell fibronectin (=35,000 cpm) or 1.8/~g of fibroblast 
fibronectin {=7,300 cprn) and centrifuged as outlined in Materials and Methods. After isopycnic centrifugation and fractionation 
of the gradients, the radioactivities present in 50-/~1  aliquots of each fraction were determined. Inset, left panel shows the thin-layer 
pattern of the gangliosides incorporated into the phospholipid vesicles (1) next to the GM1  ganglioside standard (2). 
BAUMANN AND ELDREDGE  Effect  of Dexamethasone  on Fibronectin Synthesis  39 activity of tyrosine aminotransferase  (9) and synthesis of at- 
acid glycoprotein (28). Fibronectin, however, is barely detect- 
able as a secretory product of primary adult hepatocytes from 
either normal or dexamethasone-treated rats (27, 28). The low 
levels occasionally  observed  in  the  culture  fluid  of primary 
hepatocytes (48) can be attributed to contaminating fibroblasts 
in the hepatocyte preparation.  For this reason, HTC cells are 
an interesting system, not only because of the relatively large 
quantities of soluble fibronectin produced, but also because of 
the glucocorticoid-regulated  synthesis.  There is  a  report that 
dexamethasone  treatment  of hepatocytes  derived  from new- 
born rats leads to an increased amount of ceil-surface localized 
fibronectin  as judged  by  fluorescent  immunological staining 
(49).  Similarly,  a  glucocorticoid-dependent  enhancement  of 
immunoreactive  fibronectin  on  the  surface  of  transformed 
human  fibroblasts  has  been  observed  (50).  In  neither  case, 
however,  has  it been  determined whether the glucocorticoid 
treatment affected the synthesis of fibronectin or the affinity of 
the cell to bind fibronectin. The occurrence of dexamethasone- 
regulated synthesis of flbronectin in HTC cells, therefore, could 
be either a  property of developmentally deregulated  hepato- 
cytes or the consequence of transformation. Future experiments 
with primary fetal hepatocytes, which are found to synthesize 
fibronectin,  and  long-term  tissue  cultures  of primary  adult 
hepatocytes,  will give  a  definite  answer.  The  reason  for  the 
partial  loss of activity of HTC-cell fibronectin  cannot at the 
present stage be elucidated.  One remaining possibility, as yet 
untested, is offered by the observation that secondary modifi- 
cation  of  newly  synthesized  glycoproteins  in  HTC  cells  is 
different  from that  in  adult  hepatocytes  (28).  However,  the 
findings that carbohydrate-free fibronectin (51) or fibronectin 
with altered oligosaccharide structure (34) exhibit normal ac- 
tivities, make this explanation appear less likely. 
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